By elucidating how genetic variants perturb AID’s roles in immunity and genome integrity, we can improve genetic screening for immune disorders and cancers, develop targeted therapies to correct or compensate for pathogenic variants and uncover broader principles of enzyme regulation applicable to other APOBEC family members. Here, AICDA is linked to cancer.